Ghadessi M, Tang R, Zhou J, Liu R, Wang C, Toyoizumi K, Mei C, Zhang L, Deng CQ, Beckman RA. A roadmap to using historical controls in clinical trials– by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG). Orphanet J Rare Dis. 2020;15(1):69.

Article  PubMed  PubMed Central  Google Scholar 

Pennello G, Thompson L. Experience with reviewing bayesian medical device trials. J Biopharm Stat. 2007;18(1):81–115.

Article  Google Scholar 

Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials.| FDA [Internet]. [cited 2022 Dec 22]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-use-bayesian-statistics-medical-device-clinical-trials

FDA. Interacting with the FDA on Complex Innovative Trial. Designs for Drugs and Biological Products [Internet]. U.S. Food and Drug Administration. FDA; 2021 [cited 2023 Apr 4]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/interacting-fda-complex-innovative-trial-designs-drugs-and-biological-products

Kotalik A, Vock DM, Donny EC, Hatsukami DK, Koopmeiners JS. Dynamic borrowing in the presence of treatment effect heterogeneity. Biostatistics. 2021;22(4):789–804.

Article  PubMed  Google Scholar 

Neuenschwander B, Capkun-Niggli G, Branson M, Spiegelhalter DJ. Summarizing historical information on controls in clinical trials. Clin Trials. 2010;7(1):5–18.

Article  PubMed  Google Scholar 

Schmidli H, Gsteiger S, Roychoudhury S, O’Hagan A, Spiegelhalter D, Neuenschwander B. Robust meta-analytic-predictive priors in clinical trials with historical control information. Biometrics. 2014;70(4):1023–32.

Article  Google Scholar 

Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S, Micallef S, Roychoudhury S, Thompson L. Use of historical control data for assessing treatment effects in clinical trials. Pharm Stat. 2014;13(1):41–54.

Article  PubMed  Google Scholar 

Carvalho LM, Ibrahim JG. On the normalized power prior. Stat Med. 2021;40(24):5251–75.

Article  PubMed  Google Scholar 

Hobbs BP, Sargent DJ, Carlin BP. Commensurate priors for incorporating historical information in clinical trials using General and Generalized Linear models. Bayesian Anal. 2012;7(3):639–74.

Article  PubMed  PubMed Central  Google Scholar 

Dejardin D, Delmar P, Warne C, Patel K, van Rosmalen J, Lesaffre E. Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: a case study and discussion of practical implementation aspects. Pharm Stat. 2018;17(2):169–81.

Article  PubMed  Google Scholar 

Isogawa N, Takeda K, Maruo K, Daimon T. A comparison between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in clinical trials with Binary endpoints. Ther Innov Regul Sci. 2020;54(3):559–70.

Article  PubMed  Google Scholar 

Lin J, Gamalo-Siebers M, Tiwari R. Ensuring exchangeability in data-based priors for a bayesian analysis of clinical trials. Pharm Stat. 2022;21(2):327–44.

Article  Google Scholar 

Wang C, Li H, Chen WC, Lu N, Tiwari R, Xu Y, Yue LQ. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies. J Biopharm Stat. 2019;29(5):731–48.

Article  PubMed  Google Scholar 

Liu M, Bunn V, Hupf B, Lin J, Lin J. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data. Stat Med. 2021;40(22):4794–808.

Article  PubMed  Google Scholar 

R Core Team. R: A Language and Environment for Statistical Computing [Internet]. R Foundation for Statistical Computing. 2022. https://www.R-project.org/

Haddad T, Himes A, Thompson L, Irony T, Nair R. Incorporation of stochastic engineering models as prior information in bayesian medical device trials. J Biopharm Stat. 2017;27(6):1089–103.

Article  PubMed  Google Scholar 

Cao H, Yao C, Yuan Y. Bayesian approach for design and analysis of medical device trials in the era of modern clinical studies. Med Rev (2021). 2023;3(5):408–24.

Article  PubMed  Google Scholar 

International Council For Harmonisation of Technical Requirements For Pharmaceuticals For Human Use (ICH). ICH E9(R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials [Internet]. 2019 [cited 2024 Jul 8]. https://database.ich.org/sites/default/files/E9-R1_Step4_Guideline_2019_1203.pdf

Weber S, Li Y, Iii JWS, Kakizume T, Schmidli H. Applying Meta-Analytic-Predictive priors with the R bayesian evidence synthesis tools. J Stat Softw. 2021;100:1–32.

Article  Google Scholar 

Makowski D, Ben-Shachar MS, Lüdecke D, bayestestR. Describing effects and their uncertainty, existence and significance within the bayesian Framework. J Open Source Softw. 2019;4(40):1541.

Article  Google Scholar